DIFLOXACIN METABOLISM AND PHARMACOKINETICS IN HUMANS AFTER SINGLE ORAL DOSES

被引：53

作者：

GRANNEMAN, GR

SNYDER, KM

SHU, VS

机构：

[1] ABBOTT LABS,DEPT CLIN RES,ABBOTT PK,IL 60064

[2] ABBOTT LABS,DEPT CLIN STAT,ABBOTT PK,IL 60064

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 1986年 / 30卷 / 05期

关键词：

D O I：

10.1128/AAC.30.5.689

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

引用

收藏

页码：689 / 693

页数：5

相关论文

共 27 条

[1] Akaike H., 1976, MATH SCI, V14, P5
[2] MULTIPLE-DOSE CIPROFLOXACIN KINETICS IN NORMAL SUBJECTS
ARONOFF, GE
KENNER, CH
SLOAN, RS
POTTRATZ, ST
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1984, 36 (03) : 384 - 388
[3] DOSE-DEPENDENT PHARMACOKINETIC STUDY OF PEFLOXACIN, A NEW ANTIBACTERIAL AGENT, IN HUMANS
BARRE, J
HOUIN, G
TILLEMENT, JP
[J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1984, 73 (10) : 1379 - 1382
[4] INVITRO EVALUATION OF A-56619 AND A-56620, 2 NEW QUINOLONES
BARRY, AL
THORNSBERRY, C
JONES, RN
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 29 (01) : 40 - 43
[5] DETERMINATION OF NORFLOXACIN, A NEW NALIDIXIC-ACID ANALOG, IN HUMAN-SERUM AND URINE BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY
BOPPANA, VK
SWANSON, BN
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1982, 21 (05) : 808 - 810
[6] CHU D T W, 1985, Drugs of the Future, V10, P543
[7] PHARMACOKINETICS AND TISSUE PENETRATION OF CIPROFLOXACIN
CRUMP, B
WISE, R
DENT, J
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 24 (05) : 784 - 786
[8] DISCHE Z, 1947, J BIOL CHEM, V167, P189
[9] PHARMACOKINETICS OF NORFLOXACIN IN HEALTHY-VOLUNTEERS AND PATIENTS WITH RENAL AND HEPATIC DAMAGE
EANDI, M
VIANO, I
DINOLA, F
LEONE, L
GENAZZANI, E
[J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1983, 2 (03) : 253 - 259
[10] INVITRO ACTIVITIES OF THE QUINOLONE ANTIMICROBIAL AGENTS A-56619 AND A-56620
ELIOPOULOS, GM
MOELLERING, AE
REISZNER, E
MOELLERING, RC
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1985, 28 (04) : 514 - 520